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12-O-Tetradecanoylphorbol 13-acetate acutely stimulated the rate of protein synthesis maximally by about 43% in termi- 
nally differentiated myocytes freshly isolated from adult rat hearts. Stimulation was rapidly expressed (within 20 min). 
The relative effects of four phorbol esters on protein synthesis was consistent with a specific effect on protein kinase C. 
Inhibition of transcription with actinomycin D had no effect on the absolute stimulation of the protein synthesis rate 
by 12-O-tetradecanoylphorbol 13-acetate. We conclude that protein kinase C may be involved in the regulation of the 
translational process. 
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1. INTRODUCTION 
The activity of Ca/phospholipid-dependent 
PKC is stimulated in vivo by diacylglycerol derived 
from agonist-stimulated hydrolysis of membrane 
phosphatidylinositols. The tumour-promoting 
phorbol esters such as TPA act as diacylglycerol 
analogues both in vitro and in vivo (review [ 11) and 
have been invaluable in implicating PKC in the 
regulation of cellular processes. In neonatal rat 
cardiac myocyte cultures, chronic (>24 h) treat- 
ment with TPA resulted in cell hypertrophy but the 
level at which TPA acted (RNA/protein synthesis 
or degradation) was not investigated [2]. TPA also 
increased DNA synthesis in cultures of terminally 
differentiated cardiac myocytes [3] and enhanced 
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c-myc protooncogene expression in neonatal rat 
heart myocyte cultures [4]. In non-cardiac cell 
cultures (GH3 pituitary tumour cells), TPA 
stimulated protein synthesis at the level of transla- 
tion initiation. This stimulation was sensitive to the 
transcriptional inhibitor, actinomycin D [5]. It was 
suggested that TPA stimulated the synthesis of an 
mRNA species that encoded an initiation factor 
whose concentration was rate-limiting. Others 
have also detected a small and as yet ill-defined 
stimulation of protein synthesis by TPA in 3T3 
fibroblast cultures [6]. Effects of TPA at the level 
of transcription required pre-exposure of cells to 
the ester for 2 h or more before maximum stimula- 
tion is attained 151. We have now examined 
whether phorbol esters have more acute effects on 
protein synthesis in freshly-isolated terminally dif- 
ferentiated myocytes prepared from adult rat 
hearts. 
2. EXPERIMENTAL 
Materials were obtained from standard sources [7] unless 
stated. Myocytes were prepared from hearts of 250-300 g fed 
male rats. Heart were perfused retrogradely at 37°C with K-H 
Published by Ekevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 209 
Volume 247, number 2 FEBS LETTERS April 1989 
buffer [8] containing 0.1% BSA (Sigma fraction V) and a 
reduced concentration (10 PM) of added Ca. After 6 min, the 
concentration of added Ca,was increased to 50~M and col- 
lagenase (Worthington Type I) was added to a concentration of 
1 mg/ml. After 5 min, the softened heart was removed from 
the cannula and myocytes were liberated by four consecutive in- 
cubations each of 5 min at 37°C with low-Ca K-H buffer con- 
taining 1 mg/ml collagenase and 2% BSA. No Ca was added to 
the first incubation medium and the three following incubations 
each contained 50 pM added Ca. Myocytes from the third and 
fourth digestions were pooled and washed 3 x in collagenase- 
free K-H buffer containing 2% BSA and 50 PM added Ca. They 
were examined by phase-contrast microscopy before use. They 
were quiescent and the proportion of rod-shaped cells was 
75-95%. 
Freshly isolated myocytes (0.35-0.55 mg myocyte pro- 
tein/tube) were preincubated with phorbol esters (diluted with 
medium from a 1 mM stock solution in DMSO) at 37°C for 
20 min in a total volume of 200 ~1 of low (50 FM) added Ca K- 
H buffer supplemented with 10 mM glucose and 2% BSA in 
siliconised glass tubes. In experiments with AM-D (diluted with 
medium from a stock solution of 5 mg/ml in DMSO), myocytes 
were preincubated with the inhibitor (5 rg/ml) for 20 min 
before the preincubation with TPA or insulin. In each experi- 
ment, myocytes from a single heart were incubated in 
quadruplicate with each agent. The mean from quadruplicate 
incubations was taken as one experimental observation. 
Measurement of protein synthesis was initiated by the addition 
of 40~1 of K-H buffer (no Ca added) containing 2.5 mM 
[U-‘?]Phe (spect. act. 4.5 dpm/pmol) and all the other amino 
acids necessary to support protein synthesis each at a concentra- 
tion of 1.25 mM. Incubations were performed at 37°C under an 
atmosphere of 95% Oa:5% COZ and myocytes were gently 
shaken at 10 min intervals. Protein synthesis was terminated at 
the times indicated by addition of 1 ml of ice-cold 5% TCA. 
Protein pellets were washed four times with 2 ml of 5% TCA 
and dissolved in 1 ml NCS (Amersham International) after 
neutralization with 50 ~1 of 0.5 M NaOH. Radioactivity incor- 
porated was measured in a toluene-based fluor. Control ex- 
periments showed that DMSO had no effect on protein 
synthesis at the concentration present. In the absence of 
myocytes, radioactivity was also linearly incorporated into 
TCA-precipitable material at about 15% of the control rate 
(results not shown). This blank was subtracted. Protein was 
measured by the biuret method [9] in a sample of cells washed 
free of BSA. ATP was measured in TCA supernates by the 
luciferase method [lo]. Statistical significance was assessed by 
a 2-tailed Student’s t test with P < 0.05 taken as being 
significant. 
3. RESULTS 
The rate of [U-14C]Phe incorporation into pro- 
tein (fig.1) was linear both under control condi- 
tions (rate = 459 pmol/h per mg protein, r = 0.996 
by regression analysis) and in the presence of 1 gM 
TPA (661 pmol Phe incorporated/h per mg pro- 
tein, r = 0.996, stimulation = 44%). The linearity 
210 
.$j 700 - 
g 
“a 
600 - 
F 
2 
2 500 - 
2 
& 
“0 400 - 
2 ._ 
2 300 - 
n. 
z 
E 
200 - 
.; 100 - 
2 
t; 
x O- _. 
.r I I I I 
e, 
s 0 20 40 60 
ct Time after addition of amino acids (min) 
Fig.1. Time course of protein synthesis in myocytes in the 
absence (0) and presence (m) of 1 PM TPA. 
with TPA indicates that the preincubation period 
was sufficient for it to produce a maximal effect. 
Results obtained in a second independent experi- 
ment were similar. Longer incubation times were 
not investigated. 
The dependence of myocyte protein synthesis 
stimulation on TPA concentration is shown in 
fig.2. The upper limit of the TPA concentration 
was set by the necessity to. dissolve it in DMSO. 
The stimulation of protein synthesis by 1 pM TPA 
was apparently maximal (fig.2 and other results 
not shown) and was 43 f 1% (mean + SE for 11 
independent observations). The stimulation was 
always less than that induced by maximally effec- 
tive concentrations of insulin (67 f 5% at 6.7 nM 
insulin, mean rt SE for 6 independent observa- 
tions). The effects of 1 pM TPA and 6.7 nM in- 
sulin were not additive (results not shown). The 
concentration of TPA giving half-maximal 
stimulation of protein synthesis was 5 + 1 nM 
(mean + SE for 6 independent observations). This 
value is similar to that reported for the stimulation 
of purified PKC by TPA [ 111. Further experiments 
investigated the relative potencies of three addi- 
tional phorbol esters (table 1). There was no 
stimulation of protein synthesis detectable at phor- 
bol ester concentrations of 0.1 nM (results not 
shopn). The rank order of potency at 10 nM phor- 
bol ester was 4+3PDD 2 TPA > PDB. The max- 
imal stimulation attained was the same for all three 
Volume 247, number 2 FEBS LETTERS April 1989 
iif 
Cl----- 
0 11 10 9 8 7 6 
- log TPA concn. (M) 
Fig.2. Concentration-dependence of the stimulation of protein 
synthesis by TPA. Results from a single, representative 
experiment are shown. Similar results were obtained with 5 
other separate preparations of myocytes. Protein synthesis was 
measured in a 1 h incubation. 
phorbol esters. The 4-a stereoisomer of PDD 
(which does not stimulate PKC [l 11) did not 
stimulate protein synthesis (table 1). None of the 
phorbol esters at a concentration of 1 pM altered 
the myocyte ATP content (control: 18 nmol/mg 
protein) at the end of the incubations (results not 
shown), indicating that phorbol esters do not 
adversely affect energy metabolism. These results 
Table 1 
Relative potencies of phorbol esters in stimulating protein 
synthesis 
Phorbol ester 
concentration 
Rate of protein 
synthesis (Qlo control) 
TPA 1 nM 103 f 2 
10 nM 128 + 1 
1fiM 144 * 1 
4-b PDD 1 nM 109 * 3 
10 nM 132 f 3 
1aM 150 f 3 
PDB 1 nM 101 f 1 
10 nM 114 + 4 
1pM 141 f 5 
4-c~ PDD 1 nM n.d. 
10 nM 101 f 3 
~/IM 103 f 1 
Protein synthesis rates in a 1 h incubation are expressed relative 
to the rate of protein synthesis in the absence of phorbol ester 
(497 + 72 pmol Phe incorporated/h per mg protein, mean f 
SE) and are the means f SE’of 3 independent experiments. 
n.d., not determined 
Table 2 
Effect of AM-D on the stimulation of myocyte protein synthesis 
by TPA or insulin 
Rate of protein synthesis (pmol phenylalanine 
incorporated/h per mg protein) 
- AM-D + AM-D (5 fig/ml) 
Absolute Increase Absolute Increase 
rate over rate over 
control control 
Control 337 f 19 n.a. 214 f 2’ . . 
TPA (1 ,uM) 474 f 22’ 138 f 5 336 f gap’ 12;: 6 
Insulin 
(6.7 nM) 542 + 38’ 205 f 20 405 + lgasb 191 f 19 
a P c 0.01 vs control 
b P < 0.05 
’ P < 0.01 vs value in the absence of AM-D 
Protein synthesis was measured for 1 h. Results are the 
means f SE of three independent experiments. n.a., not 
applicable 
suggest hat the stimulation of protein synthesis by 
phorbol esters specifically involves the activation 
of myocyte PKC. 
The acuteness of the stimulation of protein syn- 
thesis by TPA (fig.1) suggests that TPA is 
stimulating translation rather than transcription 
and this was confirmed in experiments using AM- 
D (table 2). AM-D had no effect on myocyte ATP 
content (results not shown). Although AM-D had 
no effect on the absolute stimulation of protein 
synthesis by either TPA or insulin (the latter serves 
as a control since it exerts its acute effects on pro- 
tein synthesis in heart and other cells at the level of 
translation [6,12]), it did reduce protein synthesis 
by the same absolute amount (about 130 pmol Phe 
incorporated/h per mg protein equivalent to 
3540% of the control rate) under all experimental 
conditions (table 2). This result suggests that in- 
cubation of cardiac myocytes alone induces syn- 
thesis of an mRNA species encoding a factor which 
stimulates protein synthesis independently of phor- 
bol esters and insulin. 
4. DISCUSSION 
The site in the translational process which is sen- 
sitive to PKC is uncertain. There are several 
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possibilities. Increased initiation of protein syn- 
thesis translation (e.g. by insulin [13]) is often ac- 
companied by an increase in the extent of 
ribosomal protein S6 phosphorylation (review 
[14-161). Insulin may stimulate an S6 kinase ac- 
tivity [17]. S6 is also a substrate for PKC in vitro 
[ 151. In cultured murine T lymphocytes, 
diacylglycerol stimulates S6 phosphorylation, 
albeit indirectly [ 181. Pretreatment of chick em- 
bryo fibroblasts with TPA stimulates S6 kinase ac- 
tivity in lysates prepared subsequently [19]. Thus 
the effects that we have observed may be related to 
the S6 phosphorylation state. Other stages of the 
translational process may be sensitive to PKC. 
Thus, elongation factor 2 phosphatase activity is 
enhanced in response to topical application of 
TPA on mouse epidermis [20]. However, the effect 
we report here may not involve a direct action of 
PKC on the translational machinerey. We have 
recently shown that cardiac protein synthesis is 
stimulated by an increase in intracellular pH [21]. 
TPA induces intracellular alkalinization by 
stimulation of Na+/H+ antiporter activity (review 
[22]). Thus, phorbol esters, by raising intracellular 
pH, could stimulate protein synthesis. The results 
described here suggest hat phorbol esters should 
promote cardiac protein accretion (see also [2]). 
ai-Adrenergic agonists stimulate phosphatidyl- 
inositol hydrolysis (review [23]). They also 
stimulate protein synthesis [24] and induce hyper- 
trophy [2,25] in cell cultures of neonatal rat heart 
myocytes (although it was not established whether 
the effect was exerted transcriptionally or transla- 
tionally). Furthermore, these agents enhance c- 
myc protooncogene expression [4] in the same 
system. Taken together, these findings imply a 
possible involvement of PKC in the regulation of 
cardiac myocyte protein synthesis and in the 
development of some forms of cardiac hyper- 
trophy. 
Acknowledgements: This work was supported by the UK 
Medical Research Council. We thank Dr T. Powell (University 
of Oxford) for advice on the preparation of cardiac myocytes. 
REFERENCES 
111 
I21 
131 
141 
PI 
[61 
171 
181 
191 
WI 
Ull 
WI 
[I31 
P41 
[151 
1161 
[I71 
1181 
u91 
PO1 
WI 
P21 
Castagna, M. (1987) Biol. Cell 59, 3-14. 
Henrich, C.J. and Simpson, P.C. (1988) J. Mol. Cell. 
Cardiol. 20, 1081-1085. 
Claycomb, W.C. and Moses, R.L. (1988) Dev. Biol. 127, 
257-265. 
Starksen, N.F., Simpson, PC., Bishopric, N., Coughlin, 
S.R., Lee, W.M.F., Escobedo, J.A. and Williams, L.T. 
(1986) Proc. Natl. Acad. Sci. USA 83, 8348-8350. 
Brostrom, M.A., Chin, K.-V., Cade, C., Gmitter, D. and 
Brostrom, C.O. (1987) J. Biol. Chem. 262, 16515-16523. 
Hesketh, J.E., Campbell, G.P. and Reeds, P. J. (1986) 
Biosci. Rep. 6, 797-804. 
Preedy, V.R., Smith, D.M., Kearney, N.F. and Sugden, 
P.H. (1984) Biochem. J. 222, 395-400. 
Krebs, H.A. and Henseleit, K. (1932) Hoppe-Seyler’s Z. 
Physiol. Chem. 210, 33-66. 
Gornall, A.G., Bardawill, C.J. and David, M.M. (1949) 
J. Biol. Chem. 177, 751-766. 
Stanley, P.E. and Williams, S.G. (1969) Anal. Biochem. 
29, 381-392. 
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., 
Kiddawa, U. and Nishizuka, Y. (1982) J. Biol. Chem. 
257, 7847-7851. 
Morgan, H.E., Rannels, D.E. and McKee, E.E. (1979) in: 
Handbook of Physiology, Sect. 2: The Cardiovascular 
System (Berne, R.M., Sperelakis, N. and Geiger, S.R. 
eds) vol. 1, pp.845-871, American Physiological Society, 
Bethesda, MD. 
Cobb, M.H. (1986) J. Biol. Chem. 261, 12994-12999. 
Leader, D.P. (1980) Mol. Aspects Cell. Regul. 1, 
203-233. 
Parker, P.J., Katan, M., Waterfield, M.D. and Leader, 
D.P. (1985) Eur. J. Biochem. 148, 579-586. 
Krieg, J., Hofsteenge, J. and Thomas, G. (1988) J. Biol. 
Chem. 263, 11473-l 1477. 
Hansson, A. and Ingelmann-Sundberg, M. (1985) Eur. J. 
Biochem. 151, 97-100. 
Evans, S.W. and Farrar, W.L. (1987) J. Biol. Chem. 262, 
4624-4630. 
Blenis, J. and Erikson, R.L. (1986) Proc. Natl. Acad. Sci. 
USA 83, 1733-1737. 
Gschwendt, M., Kittstein, W. and Marks, F. (1988) Bio- 
them. Biophys. Res. Commun. 153, 1129-1135. 
Fuller, S.J., Gaitanaki, C.J. and Sugden, P.H. (1989) 
Biochem. J., in press. 
Frelin, C., Vigne, P., Ladoux, A. and Lazdunski, M. 
(1988) Eur. J. Biochem. 174, 3-14. 
[23] Abdel-Latif, A.A. (1986) Pharmacol. Rev. 38, 227-272. 
1241 Meidell, R.S., Sen, A., Henderson, S.A., Slahetka, M.F. 
and Chien, K.R. (1986) Am. J. Physiol. 251, 
H1076-H1084. 
[25] Simpson, P. (1985) Circ. Res. 56, 884-894. 
212 
